Both in Biotechnology
Odyssey Therapeutics vs Prime Medicine
Over the past year ODTX returned −20.7% and PRME returned +50.8%; their daily moves had a correlation of 0.31.
ODTX −20.7% PRME +50.8%Growth of $1, one year, split-adjusted
| Metric | ODTX | PRME |
|---|---|---|
| Price | $19.54 | $4.72 |
| Market cap | $939.1M | $856.1M |
| Today | −1.46% | −9.92% |
| 1 month | −4.3% | +57.9% |
| 6 months | — | +38.4% |
| Year to date | — | +36.0% |
| 1 year | — | +4.0% |
| Revenue growth (YoY) | — | +3.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −3649.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 210.2× |
| Net cash | $310.6M | $95.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 111.1% |
| Short % of float | 13.6% | 34.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).